![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
Vanqua raises $45M; Aerovate to look for strategic alternatives
Plus, news about GSK, iTeos, Oxolife and SmallCella:
Vanqua Bio reels in $45M: The Chicago neuroscience biotech extended its Series B, a spokesperson confirmed to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.